Related Experiment Video
Updated: Apr 24, 2026

09:35
Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts
Published on: March 2, 2017
13.0K
[Contribution of embryo vitrification procedure to ART efficiency]
1Service d'histologie-embryologie-cytogénétique-CECOS, centre hospitalier universitaire Jean-Verdier, Assistance Publique-Hôpitaux de Paris, 93140 Bondy, France.
Gynecologie, Obstetrique & Fertilite
|September 7, 2014
Summary
Vitrification significantly improves embryo survival and clinical pregnancy rates compared to slow freezing in assisted reproductive technology. This method enhances embryo management for infertile couples, offering better outcomes in fertility treatments.
Area of Science:
- Reproductive Medicine
- Embryology
- Cryobiology
Context:
- Assisted Reproductive Technology (ART) management for infertile couples.
- Comparison of embryo cryopreservation techniques: vitrification versus slow freezing (SF).
- Evaluation of frozen-thawed embryo transfers (FETs).
Purpose:
- To assess the impact of embryo vitrification on management of infertile couples.
- To compare vitrification with SF regarding embryo survival and clinical pregnancy rates.
- To analyze the effectiveness of vitrification at different embryo developmental stages.
Summary:
- Vitrification demonstrated significantly higher survival rates (SR) and intact survival rates (ISR) compared to SF (97.0% vs. 72.7% for SR, 91.5% vs. 49.8% for ISR, P<10(-4)).
- Clinical pregnancy rates (CPR) were significantly higher following vitrification (26.5%) versus SF (18.1%, P=0.0002).
- At the blastocyst stage, vitrification yielded a substantially improved ISR (94.5% vs. 21.4%, P<10(-4)) and increased FETs at this stage (18.1% vs. 2.5%, P<10(-4)).
Impact:
- Vitrification enhances embryo preservation and increases pregnancy rates after thawing in ART.
- The procedure supports the trend towards extended embryo culture and vitrification in fertility treatments.
- Further prospective randomized studies are needed to confirm improved cumulative birth rates at the blastocyst stage.

